Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • AMD is converting aggressive capital spending into expanded manufacturing capacity.
  • The planned capacity increase should boost supply of AMD chips.
  • AMD will roll out differentiated product sets enabled by the added capacity.
  • Analysts project revenue expansion tied to the capacity and product strategy.
  • Margins are expected to improve as higher-volume production scales.
  • A tactical long trade recommends a $140 entry, $175 target, and $120 stop over ~45 trading days.

Latest Articles

Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
Apr 15, 2026
Avery Klein
Press Releases

Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection

Aligos Therapeutics has entered an exclusive license agreement with Xiamen Amoytop Biotech Co., Ltd. to develop and commercialize pevifoscorvir sodium for chronic hepatitis B virus infection in Greater China. Aligos received a $25 million upfront payment and may earn up to $420 million in milestones plus royalties. Amoytop will fund development and…

ALGS
Safe Harbor Financial Fourth Quarter and Full Year 2025 Results, Highlighting Sequential 12% Sales Growth, Balance Sheet Transformation and Operational Progress
Apr 15, 2026
Avery Klein
Press Releases

Safe Harbor Financial Fourth Quarter and Full Year 2025 Results, Highlighting Sequential 12% Sales Growth, Balance Sheet Transformation and Operational Progress

Safe Harbor Financial reported a 12% sequential revenue increase in Q4 2025, with improved loan program income driven by an extended and enhanced credit union agreement. The company eliminated nearly all $18 million debt and ended 2025 with $6.8 million cash and positive stockholders' equity of $8.2 million, a remarkable improvement from a $12.3 mi…

SHFS
Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto
Apr 15, 2026
Priya Menon
Press Releases

Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto

Picard Medical, parent of SynCardia Systems, announced it will present the next-generation fully implantable Total Artificial Heart platform at the 2026 International Society for Heart and Lung Transplantation (ISHLT) meeting. This announcement highlights ongoing innovation in mechanical circulatory support for end-stage heart failure and underscor…

PMI
Bilibili Inc. Files Its 2025 Annual Report on Form 20-F
Apr 15, 2026
Hana Yamamoto
Press Releases

Bilibili Inc. Files Its 2025 Annual Report on Form 20-F

Bilibili Inc., a leading Chinese video community company, announced the filing of its annual report on Form 20-F for the fiscal year ending December 31, 2025, with the U.S. Securities and Exchange Commission. The report includes audited consolidated financial statements and is available online and by request to shareholders and ADS holders.

BILI
Remitly App Launches in ChatGPT
Apr 15, 2026
Derek Hwang
Press Releases

Remitly App Launches in ChatGPT

Remitly Global, Inc. has introduced its app on the ChatGPT platform, becoming the first cross-border money transfer company to do so. This integration allows users to explore exchange rates and delivery options directly within ChatGPT, streamlining the process for customers in the US, Canada, and the UK before completing transfers on Remitly's app …

RELY
Kailera Therapeutics Announces Pricing of Initial Public Offering
Apr 15, 2026
Priya Menon
Press Releases

Kailera Therapeutics Announces Pricing of Initial Public Offering

Kailera Therapeutics, a clinical-stage biotech company specializing in advanced obesity treatments, announced the pricing of its IPO at $16 per share, expected to raise approximately $625 million before expenses. The company plans to list its common stock on Nasdaq under the ticker KLRA on April 17, 2026. The funds raised aim to support Kailera's c…

KLRA
Bilibili Publishes 2025 Environmental, Social and Governance Report
Apr 15, 2026
Caleb Monroe
Press Releases

Bilibili Publishes 2025 Environmental, Social and Governance Report

Bilibili Inc., a leading Chinese video community platform, has published its 2025 Environmental, Social and Governance (ESG) Report. The report details the company's progress in adopting sustainable and responsible business practices, aiming to create value for users, creators, employees, partners, and the broader community. The report is available…

BILI
Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2026
Apr 15, 2026
Ajmal Hussain
Press Releases

Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2026

Manhattan Bridge Capital, Inc. reported a slight decrease in net income for Q1 2026 compared to the same period in 2025, with net income of approximately $1.27 million down 7.2% primarily due to lower revenue from reduced loan origination activity and loan receivables. Despite this, the company saw reduced interest expenses and an encouraging level…

LOAN
Announcement of AGM Results
Apr 15, 2026
Caleb Monroe
Press Releases

Announcement of AGM Results

Kaspi.kz held its Annual General Meeting on April 15, 2026, approving the 2025 audited financial statements, a dividend of 850 KZT per common share, and reappointing Deloitte LLP as external auditor. The company also approved stock option awards as part of long-term incentives for Board Members.

KSPI
Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases
Apr 15, 2026
Leila Farooq
Press Releases

Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases

Radiopharm Theranostics announced the completion of patient enrollment in their U.S. Phase 2b imaging trial for RAD 101, a novel imaging agent targeting fatty acid synthase for detecting recurrent brain metastases. Interim data shows 90% concordance with MRI, with full data anticipated in June 2026. The company plans to advance RAD 101 into a Phase…

RADX
Balchem Corporation Announces Quarterly Conference Call for First Quarter 2026 Financial Results on April 30, 2026
Apr 15, 2026
Avery Klein
Press Releases

Balchem Corporation Announces Quarterly Conference Call for First Quarter 2026 Financial Results on April 30, 2026

Balchem Corporation will release its first quarter 2026 financial results before the market opens on April 30, 2026, followed by a conference call hosted by its CEO and CFO to discuss the results. Balchem operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, delivering specialty ingredients globall…

BCPC
Brookfield Corporation Announces Pricing of C$500 Million of Medium-Term Notes Due 2036 and C$250 Million Re-Opening of Medium-Term Notes Due 2055
Apr 15, 2026
Jordan Park
Press Releases

Brookfield Corporation Announces Pricing of C$500 Million of Medium-Term Notes Due 2036 and C$250 Million Re-Opening of Medium-Term Notes Due 2055

Brookfield Corporation announced the pricing of C$500 million medium-term notes due 2036 and a C$250 million re-opening of its existing medium-term notes due 2055. The notes offer attractive yields and carry solid investment-grade credit ratings. Proceeds will be utilized for general corporate purposes, reflecting ongoing strategic financing activi…

BN
MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia
Apr 15, 2026
Avery Klein
Press Releases

MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia

MeiraGTx announced positive three-year data from its Phase 1 AQUAx study evaluating AAV-hAQP1 gene therapy for grade 2/3 late radiation-induced xerostomia. The data show sustained clinical improvements in patient-reported symptoms and increased saliva flow rates, with the therapy demonstrating a strong safety profile. This durable, one-time treatme…

MGTX
Harrow Announces the Issuance of J-Code for IOPIDINE® 1%
Apr 15, 2026
Derek Hwang
Press Releases

Harrow Announces the Issuance of J-Code for IOPIDINE® 1%

Harrow announced that the FDA-approved ophthalmic drug IOPIDINE® 1% has received a permanent J-Code (J2374) by CMS, effective July 1, 2026. The J-Code enables physicians to receive reimbursement for administrating IOPIDINE 1% during in-office procedures to prevent intraocular pressure spikes, a common complication of glaucoma-related laser surgerie…

HROW
Redefining Enterprise Engagement at InnoEX Hong Kong: Aurora Mobile's EngageLab Unveils AI-First Solutions
Apr 15, 2026
Jordan Park
Press Releases

Redefining Enterprise Engagement at InnoEX Hong Kong: Aurora Mobile's EngageLab Unveils AI-First Solutions

Aurora Mobile Limited (NASDAQ: JG) showcased its AI-driven customer engagement platform, EngageLab, at InnoEX Hong Kong, introducing innovative solutions to streamline omnichannel communication, reduce integration complexity, and enhance AI-powered customer support. EngageLab demonstrated intelligent fallback workflows, agile customization via deve…

JG